Adaptive Biotechnologies Corp (ADPT) Earnings
Adaptive Biotechnologies Corp's most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Jul 29, 2026
From the latest earnings 8-K
Revenue • FY2025
$276.98M
▲ 54.8%YoY
Diluted EPS • FY2025
$-0.39
▲ 63.9%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from ADPT's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $276.98M | -$59.5M | $205.62M | $-0.39 | -$48.95M | -20.6% | +54.8% |
| FY2024 | $178.96M | -$159.49M | $106.88M | $-1.08 | -$98.88M | -90.8% | +5.1% |
| FY2023 | $170.28M | -$225.25M | $94.72M | $-1.56 | -$167.02M | -133.3% | -8.1% |
| FY2022 | $185.31M | -$200.19M | $127.4M | $-1.40 | -$200.29M | -108.0% | +20.1% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Jul 29, 2026 | 8-K (2.02) | 0001193125-26-323753EDGAR |
| May 5, 2026 | 8-K (2.02) | 0001193125-26-206455EDGAR |
| Feb 5, 2026 | 8-K (2.02) | 0001193125-26-039409EDGAR |
| Jan 12, 2026 | 8-K (2.02) | 0001193125-26-009840EDGAR |
| Nov 5, 2025 | 8-K (2.02) | 0001193125-25-266974EDGAR |
| Aug 5, 2025 | 8-K (2.02) | 0000950170-25-103058EDGAR |
| May 1, 2025 | 8-K (2.02) | 0000950170-25-061851EDGAR |
| Feb 11, 2025 | 8-K (2.02) | 0000950170-25-017915EDGAR |
Never miss a ADPT filing.
Get an email when ADPT files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.